XABAN 5 Tablet

About XABAN 5 Tablet

Made by The ACME Laboratories Ltd., XABAN 5 is a tablet whose active ingredient is Apixaban. It is further used in the treatment of deep vein thrombosis.

There are 16 brands of Apixaban listed in Bangladesh. The lowest listed price is Antixa 2.5 mg Tablet at ৳ 10.00 per unit.

What is XABAN 5 Tablet?

XABAN 5 comes as a tablet with 5 mg of Apixaban, from The ACME Laboratories Ltd. Doctors use it to lower the chance of stroke in people with an irregular heartbeat called nonvalvular atrial fibrillation. It is also used to treat deep vein thrombosis. Use it only as your doctor directs.

Uses of XABAN 5

It is further used in the treatment of deep vein thrombosis. It is also used to prevent deep vein thrombosis, which can lead to pulmonary embolism, in people who have had hip or knee replacement surgery. XABAN 5 is used in adults to reduce the risk of stroke and systemic embolism in people with nonvalvular atrial fibrillation. Your doctor will determine if this medicine is appropriate for your condition.

How to use XABAN 5

Swallow the tablet with water. XABAN 5 is taken by mouth. Do not stop taking this medicine without talking to your doctor first, as stopping suddenly can increase the risk of blood clots. Do not change the dose or stop early without asking your doctor.

Side effects of XABAN 5

The most important risk is bleeding, as the medicine reduces clotting. Call your doctor right away if you notice any unusual bleeding or signs of an allergic reaction, such as swelling, difficulty breathing, or severe rash. A skin rash or severe allergic reaction can also occur. Tell your doctor or pharmacist if you notice any unusual symptoms or any bleeding that does not stop. Ask your doctor or pharmacist for a full list of possible side effects and how to recognise them.

Safety and precautions

It is not known if Apixaban passes into breast milk, so discuss breastfeeding with your doctor. Before taking XABAN 5, tell your doctor about all your health conditions and medicines. It is unknown whether it passes into breast milk, so breastfeeding mothers should ask their doctor. Ask your doctor first if any of these apply to you.

Frequently asked questions

What is XABAN 5 used for?

It is further used in the treatment of deep vein thrombosis. It is also used to prevent deep vein thrombosis, which can lead to pulmonary embolism, in people who have had hip or knee replacement surgery.

How is XABAN 5 used?

Swallow the tablet with water. XABAN 5 is taken by mouth.

What are the side effects of XABAN 5?

The most important risk is bleeding, as the medicine reduces clotting. Call your doctor right away if you notice any unusual bleeding or signs of an allergic reaction, such as swelling, difficulty breathing, or severe rash.

Can I use XABAN 5 in pregnancy or while breastfeeding?

It is not known if Apixaban passes into breast milk, so discuss breastfeeding with your doctor. Before taking XABAN 5, tell your doctor about all your health conditions and medicines.

Indications

Apixaban is a factor Xa inhibitor indicated:
  • To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
  • For the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery
  • ... Read more
Apixaban is a factor Xa inhibitor indicated:
  • To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
  • For the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery
  • For the treatment of DVT and PE, and for the reduction in the risk of recurrent DVT and PE following initial therapy

Pharmacology

Apixaban acts by inhibiting coagulation, and thus prevents development of blood clots. As a result of FXa inhibition, apixaban prolongs clotting tests such as prothrombin time (PT), INR, and activated partial thromboplastin time (aPTT). Changes observed in these clotting tests at the expected therapeutic dose, however, are small, subject to a high degree of variability, and not useful in monitoring the anticoagulation effect of apixaban.

Dosage & Administration

Recommended Dose: The recommended dose of Apixaban for most patients is 5 mg taken orally twice daily.

Dosage Adjustments: The recommended dose of Apixaban is 2.5 mg twice daily in patients with any 2 of the following characteristics: age ≥80 years, body weight ≤60 kg, serum creatinine ≥1.5mg/dl.

CYP3A4 and P-gp inhibitors: When Apixaban is coadministered with drugs that are strong dual inhibitors of cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) (e.g. ketoconazole, itraconazole, ritonavir, clarithromycin) the recommended dose is 2.5 mg twice daily.

Missed Dose: If a dose of Apixaban is not taken at the scheduled time, the dose should be taken as soon as possible on the same day and twice-daily administration should be resumed. The dose should not be doubled to make up for a missed dose.

Discontinuation for Surgery and Other Interventions: Apixaban should be discontinued at least 48 hours prior to elective surgery or invasive procedures with a moderate or high risk of unacceptable or clinically significant bleeding. Apixaban should be discontinued at least 24 hours prior to elective surgery or invasive procedures with a low risk of bleeding or where the bleeding would be non-critical in location and easily controlled.

Switching from or to Apixaban: Switching from warfarin to Apixaban: Warfarin should be discontinued and Apixaban started when the international normalized ratio (INR) is below 2.0.

Switching from Apixaban to warfarin: Apixaban affects INR, so that INR measurements during co-administration with warfarin may not be useful for determining the appropriate dose of warfarin. If continuous anticoagulation is necessary, discontinue Apixaban and begin both a parenteral anticoagulant and warfarin at the time the next dose of Apixaban would have been taken, discontinuing the parenteral anticoagulant when INR reaches an acceptable range.

Switching between Apixaban and anticoagulants other than warfarin: Discontinue one being taken and begin the other at the next scheduled dose.

Interaction

Apixaban is a substrate of both CYP3A4 and P-gp. Inhibitors of CYP3A4 and P-gp increase exposure to Apixaban and increase the risk of bleeding. Inducers of CYP3A4 and P-gp decrease exposure to Apixaban and increase the risk of stroke.

Contraindications

Apixaban is contraindicated in patients with the following conditions: Active pathological bleeding. Severe hypersensitivity reaction to Apixaban (i.e. anaphylactic reactions).

Side Effects

Apixaban can cause a skin rash or severe allergic reaction.

Pregnancy & Lactation

Pregnancy: There are no adequate and well-controlled studies of Apixaban in pregnant women. Treatment is likely to increase the risk of hemorrhage during pregnancy and delivery. Apixaban should be used during pregnancy only if the potential benefit outweighs the potential risk to the mother and fetus.

Labor and Delivery: Safety and effectiveness of Apixaban during labor and delivery have not been studied in clinical trials. Consider the risks of bleeding and of stroke in using Apixaban in this condition.

Nursing Mothers: It is unknown whether Apixaban or its metabolites are excreted in human milk. Women should be instructed either to discontinue breastfeeding or to discontinue Apixaban therapy, taking into account the importance of the drug to the mother.

Precautions & Warnings

Increased Risk of Stroke with Discontinuation of Apixaban Discontinuing Apixaban in the absence of adequate alternative anticoagulation increases the risk of thrombotic events. An increased rate of stroke was observed during the transition from Apixaban to warfarin in clinical trials in patients with nonvalvular atrial fibrillation. If Apixaban must be discontinued for a reason other than pathological bleeding, consider coverage with another anticoagulant.

Overdose Effects

There is no antidote to Apixaban. Overdose of Apixaban increases the risk of bleeding. Activated charcoal may be useful in the management of Apixaban overdose.

Storage Conditions

Keep in a dry place and store below 30°C. Protect from light and keep out of the reach of children.

Alternative brands of Apixaban

Other brands with the same generic name, cheapest first.

Antixa Tablet

2.5 mg

Apixaban

General Pharmaceuticals Ltd.

৳ 10.00 per unit

Apiban Tablet

2.5 mg

Apixaban

NIPRO JMI Pharma Ltd.

৳ 15.00 per unit

Apixa Tablet

2.5 mg

Apixaban

Beximco Pharmaceuticals Ltd.

৳ 15.00 per unit

Antixa Tablet

5 mg

Apixaban

General Pharmaceuticals Ltd.

৳ 20.00 per unit

Apiban Tablet

5 mg

Apixaban

NIPRO JMI Pharma Ltd.

৳ 25.00 per unit

Apixa Tablet

5 mg

Apixaban

Beximco Pharmaceuticals Ltd.

৳ 25.00 per unit

See all 16 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.